Sign inGet started

Nolan Lisa

Insider CIK 1661400 · RNN Chief Business Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RNN REXAHN PHARMACEUTICALS, IN M Exercise deriv2019-02-282019-03-011,625— $03,250SEC↗
RNN REXAHN PHARMACEUTICALS, IN M Exercise2019-02-282019-03-011,625— $023,250SEC↗
RNN REXAHN PHARMACEUTICALS, IN P Buy2019-01-302019-01-3120,000$0.65 $13.0K21,625SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2019-01-252019-01-25130,000— $0130,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN M Exercise deriv2018-02-282018-03-021,625— $04,875SEC↗
RNN REXAHN PHARMACEUTICALS, IN M Exercise2018-02-282018-03-021,625— $01,625SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2018-01-262018-01-3042,101— $042,101SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2017-01-202017-01-24315,000— $0315,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2017-01-202017-01-2465,000— $065,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2016-07-062016-07-081,200,000— $01,200,000SEC↗